Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice

Pharmacology Biochemistry and Behavior

Volumn 130, Issue , 2015, Pages 9-14

  Neis, Vivian Binder ^a   Moretti, Morgana ^a,b   Manosso, Luana Meller ^a   Lopes, Mark W ^a   Leal, Rodrigo Bainy ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

Agmatine; Antidepressants; Depression; NMDA

Indexed keywords

AGMATINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DIZOCILPINE; FLUOXETINE; IMIPRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; DIZOCILPINE MALEATE;

ADULT; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; FEMALE; IMMOBILITY; MONOAMINERGIC SYSTEM; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; TAIL SUSPENSION TEST; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; IMMOBILIZATION; MOTOR ACTIVITY;

ANIMALIA; MUS;

AGMATINE; ANIMALS; ANTIDEPRESSIVE AGENTS; BUPROPION; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; FLUOXETINE; HINDLIMB SUSPENSION; IMIPRAMINE; MICE; MOTOR ACTIVITY;

EID: 84920913816     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.12.009     Document Type: Article

References (62)

1. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, and D.S. Charney Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 2000 351 354
2. O. Berton, and E.J. Nestler New approaches to antidepressant drug discovery: beyond monoamines Nat Rev Neurosci 7 2006 137 151
3. C.M. Chang, S. Sato, and C. Han Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression CNS Drugs 27 2013 S21 S27
4. C.R. Conway, J.T. Chibnall, P. Cumming, M.A. Mintun, M.A.I. Gebara, and D.C. Perantie Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study Psychiatry Res Neuroimaging 221 2014 231 239
5. M.P. Cunha, D.G. Machado, L.E.B. Bettio, J.C. Capra, and A.L.S. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Prog Neuro-Psychopharmacol 32 2008 1913 1920
6. P.S. D'Aquila, A.T. Peana, V. Carboni, and G. Serra Exploratory behaviour and grooming after repeated restraint and chronic mild stress: effect of desipramine Eur J Pharmacol 399 2000 43 47
7. E. Dailly, F. Chenu, C.E. Renard, and M. Bourin Dopamine, depression and antidepressants Fundam Clin Pharmacol 18 2004 601 607
8. C. DeBattista Augmentation and combination strategies for depression J Psychopharmacol 20 2006 11 18
9. S. Demehri, H. Homayoun, H. Honar, K. Riazi, K. Vafaie, and F. Roushanzamir Agmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxide Neuropharmacology 45 2003 534 542
10. A.S. Elhwuegi Central monoamines and their role in major depression Prog Neuro-Psychopharmacol 28 2004 435 451
11. A.E. Freitas, L.E. Bettio, V.B. Neis, M. Moretti, C.M. Ribeiro, and M.W. Lopes Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice J Psychiatr Res 58 2014 137 146
12. A.E. Freitas, J. Budni, K.R. Lobato, R.W. Binfare, D.G. Machado, and J. Jacinto Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system Prog Neuro-Psychopharmacol 34 2010 335 343
13. G.M. Gilad, K. Salame, J.M. Rabey, and V.H. Gilad Agmatine treatment is neuroprotective in rodent brain injury models Life Sci 58 1996 41 46
14. Z.H. Gong, Y.F. Li, N. Zhao, H.J. Yang, R.B. Su, and Z.P. Luo Anxiolytic effect of agmatine in rats and mice Eur J Pharmacol 550 2006 112 116
15. A. Halaris, H. Zhu, Y.Z. Feng, and J.E. Piletz Plasma agmatine and platelet imidazoline receptors in depression Ann N Y Acad Sci 881 1999 445 451
16. K. Hashimoto, A. Sawa, and M. Iyo Increased levels of glutamate in brains from patients with mood disorders Biol Psychiatry 62 2007 1310 1316
17. H. Hori, and H. Kunugi The efficacy of pramipexole, a dopamine receptor agonist, as an adjunctive treatment in treatment-resistant depression: an open-label trial Sci World J 12 2012 1 8
18. D.C. Javitt, and S.R. Zukin Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels Mol Pharmacol 35 1989 387 393
19. M.P. Kaster, A.O. Rosa, A.R.S. Santos, and A.L.S. Rodrigues Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test Int J Neuropsychopharmacol 8 2005 601 606
20. R.C. Kessler, P. Berglund, O. Demler, R. Jin, D. Koretz, and K.R. Merikangas The epidemiology of major depressive disorder - results from the National Comorbidity Survey Replication (NCS-R) JAMA J Am Med Assoc 289 2003 3095 3105
21. O. Keynan, Y. Mirovsky, S. Dekel, V.H. Gilad, and G.M. Gilad Safety and efficacy of dietary agmatine sulfate in lumbar disc-associated radiculopathy. An open-label, dose-escalating study followed by a randomized, double-blind, placebo-controlled trial Pain Med 11 2010 356 368
22. J.K. Kiecolt-Glaser, and R. Glaser Depression and immune function - central pathways to morbidity and mortality J Psychosom Res 53 2002 873 876
23. N.R. Kotagale, S.J. Tripathi, M.M. Aglawe, C.T. Chopde, M.J. Umekar, and B.G. Taksande Evidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim test Pharmacol Biochem Behav 107 2013 42 47
24. X. Li, J.M. Witkin, A.B. Need, and P. Skolnick Enhancement of antidepressant potency by a potentiator of AMPA receptors Cell Mol Neurobiol 23 2003 419 430
25. Y.F. Li, Z.H. Gong, J.B. Cao, H.L. Wang, Z.P. Luo, and J. Li Antidepressant-like effect of agmatine and its possible mechanism Eur J Pharmacol 469 2003 81 88
26. S. Maeng, C.A. Zarate, J. Du, R.J. Schloesser, J. McCammon, and G. Chen Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors Biol Psychiatry 63 2008 349 352
27. L.M. Manosso, V.B. Neis, M. Moretti, J.F. Daufenbach, A.E. Freitas, and A.R. Colla Antidepressant-like effect of alpha-tocopherol in a mouse model of depressive-like behavior induced by TNF-alpha Prog Neuro-Psychopharmacol 46 2013 48 57
28. M. Mantovani, R. Pertile, J.B. Calixto, A.R.S. Santos, and A.L.S. Rodrigues Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway Neurosci Lett 343 2003 1 4
29. H. Mitani, Y. Shirayama, T. Yamada, K. Maeda, C.R. Ashby, and R. Kawahara Correlation between plasma levels of glutamate, alanine and serine with severity of depression Prog Neuro-Psychopharmacol 30 2006 1155 1158
30. M. Moretti, A.E. Freitas, J. Budni, S.C. Fernandes, O. Balen Gde, and A.L. Rodrigues Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test Behav Brain Res 225 2011 328 333
31. V.B. Neis, L.M. Manosso, M. Moretti, A.E. Freitas, J. Daufenbach, and A.L.S. Rodrigues Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration Behav Brain Res 261 2014 336 344
32. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
33. G. Olmos, N. DeGregorio-Rocasolano, M.P. Regalado, T. Gasull, M.A. Boronat, and R. Trullas Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor Br J Pharmacol 127 1999 1317 1326
34. A. Onal, Y. Delen, S. Ulker, and N. Soykan Agmatine attenuates neuropathic pain in rats: Possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum Life Sci 73 2003 413 428
35. M. Papp, and E. Moryl Antidepressant activity of noncompetitive and competitive NMDA õreceptor antagonists in a chronic mild stress model of depression Eur J Pharmacol 263 1994 1 7
36. A.A. Patkar, and C.U. Pae Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder CNS Drugs 27 2013 S29 S37
37. I.A. Paul, and P. Skolnick Glutamate and depression - clinical and preclinical studies Ann NY Acad Sci 1003 2003 250 272
38. J.E. Piletz, F. Aricioglu, J.T. Cheng, C.A. Fairbanks, V.H. Gilad, and B. Haenisch Agmatine: clinical applications after 100 years in translation Drug Discov Today 18 2013 880 893
39. J.E. Piletz, D.N. Chikkala, and P. Ernsberger Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2-adrenergic receptors J Pharmacol Exp Ther 272 1995 581 587
40. D.J. Reis, and S. Regunathan Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21 2000 187 193
41. G.Z. Reus, R.B. Stringari, K.F. Ribeiro, A.K. Ferraro, M.F. Vitto, and P. Cesconetto Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain Behav Brain Res 221 2011 166 171
42. J.C. Roberts, B.M. Grocholski, K.F. Kitto, and C.A. Fairbanks Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse J Pharmacol Exp Ther 314 2005 1226 1233
43. A.L. Rodrigues, J.B. Rocha, C.F. Mello, and D.O. Souza Effect of perinatal lead exposure on rat behaviour in open-field and two-way avoidance tasks Pharmacol Toxicol 79 1996 150 156
44. Z. Rogoz Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy Pharmacol Rep 65 2013 1535 1544
45. Z. Rogoz, G. Skuza, J. Maj, and W. Danysz Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats Neuropharmacology 42 2002 1024 1030
46. G. Sanacora, D.L. Rothman, G. Mason, and J.H. Krystal Clinical studies implementing glutamate neurotransmission in mood disorders Ann NY Acad Sci 1003 2003 292 308
47. G. Sanacora, C.A. Zarate, J.H. Krystal, and H.K. Manji Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Nat Rev Drug Discov 7 2008 426 437
48. A.R. Santos, V.M. Gadotti, G.L. Oliveira, D. Tibola, A.F. Paszcuk, and A. Neto Mechanisms involved in the antinociception caused by agmatine in mice Neuropharmacology 48 2005 1021 1034
49. B. Shopsin The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study Acta Neuropsychiatr 25 2013 113 118
50. P. Skolnick Antidepressants for the new millennium Eur J Pharmacol 375 1999 31 40
51. P. Skolnick, B. Legutko, X. Li, and F.P. Bymaster Current perspectives on the development of non-biogenic amine-based antidepressants Pharmacol Res 43 2001 411 422
52. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test - a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370
53. R. Stryjer, D. Budnik, T. Ebert, T. Green, L. Polak, and S. Weizman Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs - an open-label study Clin Neuropharmacol 37 2014 79 81
54. B.G. Taksande, N.R. Kotagale, S.J. Tripathi, R.R. Ugale, and C.T. Chopde Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine Neuropharmacology 57 2009 415 424
55. W.P. Wang, A.H. Iyo, J. Miguel-Hidalgo, S. Regunathan, and M.Y. Zhu Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons Brain Res 1084 2006 210 216
56. N. Wu, R.B. Su, and J. Li Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence Cell Mol Neurobiol 28 2008 629 641
57. X.C. Yang, and D.J. Reis Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons J Pharmacol Exp Ther 288 1999 544 549
58. C.A. Zarate, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, and D.A. Luckenbaugh A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864
59. M.P. Zeidan, A.D.E. Zomkowski, A.O. Rosa, A.L.S. Rodrigues, and N.H. Gabilan Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test Eur J Pharmacol 565 2007 125 131
60. M.Y. Zhu, J.E. Piletz, A. Halaris, and S. Regunathan Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells Cell Mol Neurobiol 23 2003 865 872
61. A.D.E. Zomkowski, L. Hammes, J. Lin, J.B. Calixto, A.R.S. Santos, and A.L.S. Rodrigues Agmatine produces antidepressant-like effects in two models of depression in mice Neuroreport 13 2002 387 391
62. A.D.E. Zomkowski, A.O. Rosa, J. Lin, A.R.S. Santos, J.B. Calixto, and A.L.S. Rodrigues Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test Brain Res 1023 2004 253 263